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Peripheral Expression of Self-MHC-II Influences
the Reactivity and Self-Tolerance of Mature CD4
T Cells: Evidence from a Lymphopenic T Cell Model
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Results
Experimental Design
The present study utilized an adoptive transfer system to
assess the influence of self-MHC-II molecules on CD4
T cell reactivity. Specifically, we adoptively transferred
mature CD4 T cells into either MHC-II or MHC-II null
(MHC-IIo) (Cosgrove et al., 1991; Grusby et al., 1991) host
mice and then assessed the reactivity of the transferred
CD4 T cells both in vivo and in vitro. In vivo reactivity of
the transferred CD4 T cells was assessed by rejection
responses against skin grafts expressing foreign, self-,
or no MHC class II antigens; in vitro reactivity was as-
sessed by anti-TCR-induced CD69 upregulation. How-
ever, in selecting donor and host mouse strains for our
study, we considered that any immune reaction of the
MHC-IIo host mouse against the transferred CD4 T cells
might alter the reactivity of those CD4 T cells. We were
especially concerned that CD8 T cells resident in MHC-
IIo mice might react against persistent minor histoincom-
patibilities expressed on transferred B6 CD4 T cells,
as MHC-IIo mice were originally of strain 129 origin
(Grusby et al., 1991). To circumvent such a possibility,
we generated ZAPoMHC-IIo double-deficient mice to use
as MHC-II null host animals because host mice lack-
ing ZAP-70 protein tyrosine kinase are devoid of all  Figure 1. Experimental Design
T cells (Negishi et al., 1995; Wiest et al., 1997) and cannot T cell-deficient ZAPoMHC-IIo or ZAPoMHC-II mice that differed in
their expression of I-Ab molecules were each grafted with threereact against histocompatibility disparities. Thus, we
different tailskin grafts from bm12, B6, and MHC-IIo mice. Two toused as host animals ZAPoMHC-IIo and ZAPoMHC-II
four weeks later, after the skin grafts had completely healed in, themice, which are both equally devoid of  T cells but
mice were reconstituted with 2  106 B6 CD4 lymph node T cells.
contain B cells and all other non-T hematopoietic cells.
Two to four weeks prior to the infusion of B6 CD4 T
cells into host mice, we grafted each ZAPoMHC-IIo and CD44hiCD62L) after transfer into either MHC-II or
ZAPoMHC-II host mouse with three different tailskin MHC-IIo host mice (Figure 2E).
grafts: (1) bm12 skin grafts expressing mutant Abm12
molecules (McKenzie et al., 1979, 1984), (2) B6 skin Hyperreactivity and Loss of Self-Tolerance by CD4
grafts expressing wild-type Ab molecules, and (3) MHC- T Cells in an MHC-IIo Environment
IIo skin grafts expressing no A molecules (Figure 1). We assessed in vivo CD4 T cell reactivity by evaluating
After the three grafts had fully healed, each mouse was the response of the transferred CD4 T cells to the three
reconstituted with 2 x 106 CD4 donor T cells purified different skin grafts that each reconstituted mouse bore.
from the lymph nodes of normal B6 mice. The donor Without CD4 T cell reconstitution, host mice retained
inoculum was 95% CD4 T cells, with the remaining all three skin grafts indefinitely. However, after reconsti-
cells being CD4CD8Thy1 T cells (Figure 2A). Upon tution with B6 CD4 T cells, all reconstituted ZAPoMHC-
examination of spleen cell populations from recipient IIo and ZAPoMHC-II host mice rejected their bm12 skin
mice at days 50 and 100 postreconstitution, no I-A allografts but not their MHC-IIo skin grafts (Figures 3A
cells were detected in ZAPoMHC-IIo recipient mice, and and 3B), demonstrating the MHC-II specificity of the
no CD8 T cells were detected in either ZAPoMHC-IIo or rejection response. Most remarkably, however, 36% (5
ZAPoMHC-II recipient mice (Figure 2B). More impor- of 14) of the reconstituted ZAPoMHC-IIo animals also
tantly, donor CD4 T cells increased in number after overtly rejected their B6 skin grafts (Figures 3A and
injection into both groups of recipient mice (Figure 2C) 3B), despite the fact that the B6 skin grafts and the
including those that had not been skin grafted, indicat- reconstituting B6 CD4 T cells were obtained from ge-
ing that CD4 T cells survived and expanded in host netically identical B6 mice. In fact, in addition to the
mice regardless of the presence or absence of MHC-II. animals that overtly rejected their B6 skin grafts, another
Interestingly, the donor CD4 T cells recovered from 43% (6 of 14) of reconstituted ZAPoMHC-IIo animals initi-
both ZAPoMHC-IIo and ZAPoMHC-II recipient mice ex- ated destructive rejection responses against B6 skin
pressed an activated memory phenotype (CD44hiCD62L) grafts that resulted in loss of graft volume and changes
(Figure 2D, left panels), and a time course analysis re- in graft appearance, but not in complete graft rejection
vealed that they expressed an activated memory pheno- (Figures 3C and 3D). Altogether, 79% (11 of 14) of recon-
type soon after adoptive transfer (Figure 2D, right). Frac- stituted ZAPoMHC-IIo animals initiated destructive rejec-
tionation of donor CD4 T cells into CD44low (naive) and tion responses against syngeneic B6 skin grafts. In con-
CD44hi (memory) subsets prior to adoptive transfer re- trast, none (0 of 14) of the reconstituted ZAPoMHC-II
vealed that both purified subsets proliferated and gave animals exhibited any response against B6 skin grafts,
even though the ZAPoMHC-IIo and ZAPoMHC-II hostrise to cells with an activated memory phenotype (i.e.,
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mice had been reconstituted at the same time with the in MHC-IIo mice. However, ZAPo and MHC-IIo mice were
originally of strain 129 origin so we considered the possi-identical donor CD4 T cell populations.
These results indicated that, after transfer into an bility that ZAPoMHC-IIo mice might express CD1 anti-
gens of strain 129 origin, that could have stimulatedMHC-II null host, CD4 T cells were no longer tolerant
to self-MHC-II/peptide complexes as they mediated de- CD1-reactive NK-T cells within the donor B6 CD4 T
cell inoculum to selectively expand in ZAPoMHC-IIo micestructive responses against self-MHC-II-bearing skin
grafts. The relative hyperreactivity of CD4 T cells in (Bendelac et al., 1997). In fact this was not the case
as most NK-CD4 T cells express NK1.1 and TCR-V8MHC-II null hosts was also evident in the rapidity of their
rejection responses against bm12 skin allografts. While (Bendelac et al., 1997), but reconstituted ZAPoMHC-IIo
mice were not significantly enriched in either NK1.1 orall reconstituted animals rejected bm12 skin allografts,
reconstituted ZAPoMHC-IIo animals rejected their bm12 TCR-V8 CD4 T cells (Figure 5D). We conclude that
the lymphoproliferative disorder observed in reconstitu-allografts much more rapidly than did reconstituted
ZAPoMHC-II animals, with median graft survival times ted ZAPoMHC-IIo host mice is not the result of a cryptic
donor anti-host response but rather results from dysreg-of 11.5 days versus 28 days postreconstitution (p 
104) (Figure 4A). ulated proliferation of CD4 T cells in an MHC-IIo host.
To assess in vitro the effect of the host environment
on CD4 T cell reactivity, we stimulated CD4 T cells Potential Mechanisms: Tuning versus Suppression
overnight with graded doses of anti-TCR mAb and ex- The present results demonstrate an important role for
amined their upregulation of CD69, a T cell activation peripheral MHC-II expression in regulating CD4 T cell
marker (Ziegler et al., 1993, 1994; Lucas et al., 1999). reactivity, as transfer of CD4 T cells into an MHC-II null
Although both CD4 T cell populations were of memory environment resulted in: (1) loss of self-tolerance, (2)
phenotype (Figure 2D), CD4 T cells obtained from re- hyperresponsiveness, and (3) dysregulated lymphopro-
constituted ZAPoMHC-IIo mice required 5-fold less anti- liferation. We considered two different mechanisms by
TCR mAb for half-maximal stimulation (p 103) (Figure which peripheral MHC-II expression might affect CD4
4B). Note that the in vitro hyperreactivity of CD4 T cells T cell reactivity. (1) MHC-II expression might influence
in ZAPoMHC-IIo host mice was not dependent on the CD4 T cell reactivity directly by raising the activation
presence of alloantigen-bearing skin grafts as identical threshold of individual CD4 T cells (tuning) (Grossman
results were obtained in host mice that had not been and Paul, 1992; Grossman and Singer, 1996), or (2) MHC-
skin grafted at all. II expression might influence CD4 T cell reactivity indi-
We conclude that CD4 T cells transferred into an rectly by affecting the survival or function of CD4CD25
MHC-II null host are no longer self-tolerant, as indicated regulatory T cells (suppression) (Sakaguchi, 2000; Shev-
by their destructive responses against skin grafts ex- ach, 2001).
pressing self-MHC-II determinants, and are hyperreac- To distinguish between these two potential mecha-
tive, as indicated by accelerated rejection of bm12 skin nisms, we first determined the frequency and number
allografts and by enhanced responsiveness to TCR stim- of donor CD4CD25 T cells before and after transfer
ulation. into ZAPoMHC-IIo and ZAPoMHC-II animals (Figure 6,
left panel). Remarkably, we found that most CD4CD25
T cells disappeared from ZAPoMHC-IIo mice, while theyDysregulation of CD4 T Cells
in an MHC-IIo Environment were maintained or increased in ZAPoMHC-IImice (Fig-
ure 6, left panel). Indeed, the absolute number ofUnexpectedly, we observed at late times post-CD4 T
cell reconstitution that reconstituted ZAPoMHC-IIo ani- CD4CD25 T cells present in reconstituted ZAPoMHC-
II mice was nearly 10-fold higher than in ZAPoMHC-IIomals developed generalized wasting and significant
thickening of their ears and feet (Figure 5A). This sys- mice even though both groups of mice were reconstitu-
ted at the same time with the identical CD4 T celltemic disorder occurred only in reconstituted ZAPoMHC-
IIo animals and developed regardless of whether or not inoculum (Figure 6, right panel). Thus, the hyperreactivity
and dysregulation exhibited by CD4 T cells transferredthey had been skin grafted. Histologic examination of
reconstituted ZAPoMHC-IIo mice revealed intraepithelial into MHC-II null hosts paralleled the loss of CD4CD25
regulatory T cells.infiltrations of lymphocytes admixed with small numbers
of neutrophils in multiple organs, including skin, ear, To directly assess the influence of CD4CD25 regu-
latory T cells on the in vivo reactivity of CD4 T cells,and GI tract (Figure 5B). The infiltrating lymphocytes
were CD48 T cells and so were of donor origin (Figure we engrafted ZAPoMHC-II host animals with skin grafts
and then reconstituted them with either unfractionated5C). The intraepithelial infiltrations were quite dramatic
but did not result in any actual tissue destruction as CD4 T cells (containing CD4CD25 regulatory T cells)
or CD4CD25 T cells (depleted of CD4CD25 regula-basement membranes and other structures remained
intact. Importantly, development of this lymphoprolifera- tory T cells) (Figure 7A). Neither group of ZAPoMHC-II
host mice rejected syngeneic B6 or control MHC-IIo skintive disorder occurred only in ZAPoMHC-IIo hosts, as
reconstituted ZAPoMHC-II mice remained healthy and grafts (data not shown), while both groups rejected
third-party bm12 skin allografts (Figure 7B). Importantly,asymptomatic. Indeed, intraepithelial infiltrations were
either entirely absent or much less significant in recon- ZAPoMHC-II mice reconstituted with CD4CD25 T
cells rejected their bm12 skin allografts more rapidlystituted ZAPoMHC-II host mice (Figure 5B).
The presence of nondestructive intraepithelial infiltra- than ZAPoMHC-II mice reconstituted with unfraction-
ated CD4 T cells that contained CD4CD25 regulatorytions presumably reflected the absence of target mole-
cules that could engage the TCR on donor CD4 T cells T cells (MST 15d versus MST 26d). Thus, removal of
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Figure 2. Characterization of Donor Cell Inocula and CD4 T Cell Reconstituted Mice
(A) Phenotype of purified CD4 T cells used for reconstitution. Purified CD4 T cells were obtained from B6 lymph node cells by negative
selection with antibodies against I-Ab, CD8, and Ig. Two-color flow cytometry profiles of the resulting donor cells are shown for expression
of CD4, CD8, B220, and Thy1.2.
(B) Detection and characterization of donor-derived lymphocytes in reconstituted mice. Spleen cells from reconstituted mice on days 50 and
100 postreconstitution were phenotyped and compared with unreconstituted control and normal B6 mice. Flow cytometry profiles are shown
for expression of CD4, CD8, and I-Ab. The numbers on the histograms indicate the relative frequencies of CD4, CD8, and Ia cells.
(C) Total numbers of donor-derived CD4 T cells in spleens of reconstituted mice 50 and 100 days postreconstitution. The percentage of
donor-derived CD4 T cells determined by flow cytometry was multiplied by the total number of splenocytes to determine the average number
of CD4 T cells in spleen (	 SEM).
(D) CD4 T cells in reconstituted mice express an activated memory phenotype. CD4 T cells in the lymph node, spleen, and peripheral blood
of reconstituted mice were assessed for CD62L and CD44 expression and found to express an activated memory phenotype (CD44hiCD62L)
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CD4CD25 regulatory T cells from the donor inoculum destructive responses against syngeneic MHC-II B6
skin grafts, and (3) functionally dysregulated, mediatingincreased the reactivity of CD4 T cells in MHC-II mice
against third-party skin allografts. a lymphoproliferative disorder characterized by nonde-
structive intraepithelial lymphocytic infiltrations. TheWhile CD4CD25 regulatory T cells did significantly
influence CD4 T cell reactivity in MHC-II host mice, it marked effects of absent MHC-II on CD4 T cell reactiv-
ity were due, at least in part, to reduced numbers ofwas possible that MHC-II expression might also have
influenced CD4 T cell reactivity independently of CD4CD25 regulatory T cells, as maintenance of
CD4CD25 regulatory T cells required peripheral MHC-CD4CD25 regulatory T cells. To examine this possibil-
ity, we reconstituted ZAPoMHC-IIo and ZAPoMHC-II II expression. In addition, MHC-II appeared to have a
direct influence on CD4 T cell reactivity that was inde-mice with CD4CD25 donor T cells and assayed their
response to anti-TCR crosslinking (Figure 7C). Interest- pendent of CD4CD25 regulatory T cells and which we
refer to as tuning.ingly, CD4 T cells from reconstituted ZAPoMHC-IIo mice
required less anti-TCR antibody to upregulate CD69
than CD4 T cells obtained from ZAPoMHC-IImice (p Increased CD4 T Cell Reactivity and Autoreactivity
103), even though both groups of mice were reconstitu- in MHC-II-Deficient Hosts
ted with CD4CD25 T cells that had been depleted of The present study utilized skin graft rejection responses
CD4CD25 regulatory T cells. These results indicated as an in vivo indicator of CD4 T cell reactivity. CD4
that MHC-II expression could affect CD4 T cell reactiv- T cells rejected third-party bm12 skin allografts much
ity independently of CD4CD25 regulatory T cells. more rapidly after transfer into ZAPoMHC-IIo than ZAPo
Finally, we wished to determine if the absence of MHC-II mice, indicating that they were more reactive
MHC-II expression contributed to the lymphoprolifera- in an MHC-IIo host. But an even more striking observa-
tive disorder occurring in reconstituted ZAPoMHC-IIo tion was that CD4 T cells in ZAPoMHC-IIo mice initiated
mice or whether it was entirely due to the loss of rejection responses against syngeneic B6 skin grafts.
CD4CD25 regulatory T cells. To examine this issue, The rejection responses against syngeneic B6 skin
we reconstituted ZAPoMHC-II mice with CD4CD25 grafts occurred in 80% of reconstituted ZAPoMHC-IIo
donor T cells and observed them for signs of systemic host mice, but the responses were not always of suffi-
disease. These mice did not develop systemic disease, cient intensity to induce complete graft rejection. This
and histologic examination was identical between ani- variability in response intensity might reflect variability
mals that had been reconstituted with unfractionated in the number of MHC-II Langerhans cells migrating
CD4 T cells and those that had been reconstituted from the B6 tailskin grafts to the draining nodes and
with CD4CD25 T cells (Figure 7D). The absence of contacting CD4 T cells, or it might reflect a limiting
histologic abnormalities revealed: (1) that dysregulated number of CD4 T cells able to react against syngeneic
lymphoproliferation did not occur in MHC-II hosts, re- B6 skin grafts. In either case, the generation of a rejec-
gardless of the presence or absence of CD4CD25 tion response against syngeneic B6 grafts and the mark-
regulatory T cells, and (2) that removal of CD4CD25 edly accelerated rejection of third-party bm12 skin grafts
regulatory T cells from the donor inoculum did not result together indicate that CD4 T cells transferred into
in destructive tissue responses mediated by CD4 T ZAPoMHC-IIo hosts display generally greater in vivo re-
cells against self-MHC-II/peptide complexes in the skin activity than the same CD4 T cells transferred into
or elsewhere. ZAPoMHC-II hosts. The increased in vivo respon-
We conclude that MHC-II expression is required to siveness of CD4 T cells in ZAPoMHC-IIo hosts was also
maintain CD4CD25 regulatory T cells that function to consistent with in vitro observations that such CD4 T
dampen CD4 T cell reactivity (suppression) and that cells required less TCR crosslinking to upregulate CD69
MHC-II can also dampen CD4 T cell reactivity directly expression.
in the absence of CD4CD25 regulatory T cells (tuning). It may be important that we specifically selected
ZAPoMHC-IIo and ZAPoMHC-II mice as host mice for
these studies because ZAPo mice are devoid of  TDiscussion
cells that can react against minor histocompatibilities
potentially expressed on donor B6 CD4 T cells (NegishiThe present study documents in a lymphopenic T cell
model a key role for peripheral MHC-II expression in et al., 1995; Wiest et al., 1997). We thought it necessary
to avoid potential antidonor immune responses by hostregulating CD4 T cell reactivity and self-tolerance.
Upon transfer into MHC-II deficient hosts, CD4 T cells lymphocytes because antidonor responses, even when
not lytic for the donor CD4T lymphocytes, might signifi-acquired a memory phenotype and became: (1) hyper-
reactive, as assessed by accelerated rejection of third- cantly dampen donor CD4 T lymphocyte reactivity.
While devoid of  T cells, ZAPo mice still contain Bparty bm12 skin allografts, (2) self-reactive, initiating
in both ZAPoMHC-IIo and ZAPoMHC-II hosts (left panels). To determine the rapidity with which donor CD4 T cells expressed an activated
memory phenotype after adoptive transfer, PBL of reconstituted mice were assessed at different times after reconstitution for percentage of
CD4 T cells that were CD62L (i.e., of naive phenotype) (right panel).
(E) Reconstitution of host mice with purified CD4 T cell subsets. Donor B6 CD4 T cells were fractionated into CD4CD44low (naive) and
CD4CD44hi (memory) subsets, and injected into ZAPoMHC-IIo (open bar) and ZAPoMHC-II (closed bar) host mice that had not been skin
grafted. On day 17, the number of CD4 T cells present in the spleens of host mice was determined. The number above each bar represents
the percentage of CD4 T cells that were CD62L (i.e., of naive phenotype).
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Figure 3. In Vivo Reactivity of Adoptively Transferred CD4 T Cells
(A) Skin graft rejections. Survival of bm12 (squares), B6 (diamonds), and MHC-IIo (circles) skin grafts on host mice is plotted versus time post-
CD4 T cell reconstitution of ZAPoMHC-IIo (left) and ZAPoMHC-II (right) host mice. There were 14 mice in each experimental group. Skin
grafts were considered rejected when 20% of the graft remained. Note that skin grafts on unreconstituted host mice were never rejected
and survived indefinitely.
(B) Serial photographs of skin graft rejection responses. Grafts are shown on the day of reconstitution with B6 CD4 T cells (day 0) and on
the indicated days postreconstitution. Most remarkable was the complete rejection of B6 skin grafts on 36% of CD4-reconstituted ZAPoMHC-
IIo mice as a result of both acute rejection responses (as shown here) and less dramatic persistent rejection responses.
(C) Rejection responses against B6 skin grafts. Frequency of B6 skin grafts with overt evidence of rejection responses is plotted versus time
post-CD4 T cell reconstitution of ZAPoMHC-IIo (squares) and ZAPoMHC-II (diamonds) mice. The two curves were significantly different (p 
104) by Wilcoxon Rank Sum test.
(D) Serial photographs of an incomplete rejection response against a B6 skin graft on a ZAPoMHC-IIo host mouse reconstituted with B6 CD4
T cells. Note the loss of volume and change in graft appearance with time.
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CD4 T cells significantly expanded upon transfer into
both ZAPoMHC-II and ZAPoMHC-IIo hosts. Transfer of
2  106 donor CD4 T cells resulted in over 6  106 T
cells just in the spleens of host mice, with an even
greater number residing in lymph nodes. Interestingly,
the CD4 T cells resident in both reconstituted ZAPo
MHC-IIo and ZAPoMHC-II mice were almost entirely of
memory phenotype (CD44hiCD62L) even though cells
in the original donor inoculum were mostly of naive phe-
notype (CD44lowCD62L). We found that memory cells
in the donor inoculum could engraft and expand in both
host strains, a finding compatible with the concept that
memory T cells do not require MHC-II expression to
undergo homeostatic proliferation (Swain et al., 1999).
However, we found that naive cells in the donor inoculum
could also expand in both host strains and that they
acquired an activated memory phenotype, presumably
as a consequence of their in vivo expansion (Surh and
Sprent, 2000). The finding that naive CD4 T cells ex-
panded and acquired a memory phenotype even after
transfer into ZAPoMHC-IIo host animals was contrary to
our expectation (Clarke and Rudensky, 2000; Dorfman
et al., 2000; Ernst et al., 1999; Rooke et al., 1997; Takeda
et al., 1996; Witherden et al., 2000). We do not know if
this was due to use of unirradiated ZAPoMHC-IIo host
mice or whether, despite depletion of MHC-II cells from
donor T cell populations, a few MHC-II cells were trans-
ferred into ZAPoMHC-IIo hosts in numbers too small to
be detected but in numbers sufficient to promote expan-
sion of naive T cells. As a result, we cannot completely
exclude the possibility that reconstituted ZAPoMHC-IIo
hosts may not be completely devoid of MHC-II and that
a small amount of MHC-II might have contributed to
CD4 T cell engraftment.
The dysregulated lymphoproliferation of CD4 T cells
Figure 4. In Vivo and In Vitro Reactivity of B6 CD4 T Cells after observed in reconstituted ZAPoMHC-IIo mice appears
Transfer into an MHC-IIo Host to be antigen independent and may be the result of
(A) Accelerated rejection of third-party bm12 skin grafts. Compari- unregulated, continued homeostatic proliferation in
son of bm12 skin graft rejection by B6 CD4 T cells transferred lymphopenic recipients lacking peripheral MHC-II. The
into ZAPoMHC-IIo (squares) and ZAPoMHC-II (diamonds) host mice.
lymphocytic infiltrations observed in the present studyData are from the same experiments compiled in Figure 2A, but
differ from those described in other experimental sys-here the survival of bm12 skin grafts on the different host mice is
tems with immunodeficient MHC-II mice in whichplotted on the same graph for direct comparison. The two survival
curves differ significantly (p  104) by Wilcoxon Rank Sum test. lymphocytic infiltrates were primarily limited to the large
(B) Relative in vitro responsiveness of CD4 T cells transferred into bowel (Mombaerts et al., 1993; Trobonjaca et al., 2001),
MHC-IIo and MHC-II hosts. Splenocytes from reconstituted ZAPo whereas in the present study CD4 T lymphocytic infil-
MHC-IIo (squares), reconstituted ZAPoMHC-II (diamonds), or nor-
trates involved multiple organs, including skin and themal B6 (triangles) mice were stimulated overnight with serial dilu-
entire GI tract. Most importantly, the lymphoproliferationtions of anti-TCR mAb, stained, and assessed by multicolor flow
we observed occurred only in reconstituted MHC-IIocytometry. The percent of responding CD4 splenocytes that be-
came CD69hi in response to TCR stimulation is shown versus the hosts and did not occur in MHC-II hosts, even when
concentration of stimulating anti-TCR mAb. Data are means 	 SEM the donor inoculum was depleted of CD4CD25 regula-
of three separate experiments. The mean concentration of anti-TCR tory T cells. Thus, the lymphoproliferative disorder in
mAb required for half-maximal CD69 upregulation on CD4 T cells
reconstituted ZAPoMHC-IIo mice is unique in its apparentfrom: (1) reconstituted ZAPoMHC-IIo mice was 0.28 	 .06  103
requirement for absent MHC-II expression.
g/ml), (2) reconstituted ZAPoMHC-II mice was 1.3 	 0.12  103

g/ml, and (3) normal B6 mice was 1.6 	 0.05  103 
g/ml. The
in vitro reactivity to anti-TCR mAb of B6 CD4 T cells obtained from Underlying Mechanisms and Theoretical
reconstituted ZAPoMHC-IIo mice was significantly greater than that Considerations
from either reconstituted ZAPoMHC-II or normal B6 mice (p 103).
In initiating the present studies, we considered two
mechanisms by which self-MHC-II expression might be
required for maintenance of CD4 T cell tolerance: tun-cells that are a major source of MHC-II that CD4 T cells
normally encounter. Since B cells cannot mediate skin ing of individual T cells, and suppression mediated by
a subpopulation of CD4CD25 T regulatory cells. Theallograft rejection (Auchincloss and Sachs, 1993), they
are not likely to account for the rejection responses tunable activation threshold model of T cell activation
(Grossman and Paul, 1992; Grossman and Singer, 1996)observed in the present study.
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Figure 5. Lymphoproliferative Disorder in Reconstituted Host Mice Lacking MHC-II
(A) Photographic comparison of CD4 T cell reconstituted ZAPoMHC-II (left) and ZAPoMHC-IIo (right) host mice on day 70 postreconstitution.
Note significant thickening and scaliness of ears and feet in reconstituted ZAPoMHC-IIo mouse.
(B) Intraepithelial infiltration of multiple organs of reconstituted ZAPoMHC-IIo mice. Shown are hematoxylin and eosin staining of sections of
ear (top) and esophagus (bottom) from reconstituted ZAPoMHC-II (left), reconstituted ZAPoMHC-IIo (middle), and unreconstituted ZAPoMHC-
IIo mice (right panels). Ear sections of reconstituted ZAPoMHC-IIo mice reveal a moderately cellular dermal infiltrate comprised primarily of
lymphocytes, admixed with fewer neutrophils, and extending multifocally into the overlying epidermis. Esophageal sections from reconstituted
ZAPoMHC-IIo mice reveal moderate numbers of lymphocytes within the submucosa, admixed with fewer neutrophils, and extending multifocally
into the overlying mucosal epithelium.
(C) Infiltrating lymphocytes in CD4 T cell-reconstituted mice are CD48. Immunohistochemical staining with anti-CD4 (left) and anti-CD8
(right) monoclonal antibodies of skin tissue from CD4 T cell reconstituted ZAPoMHC-IIo mice.
(D) NK-CD4 T cells do not selectively expand in reconstituted ZAPoMHC-IIo mice. CD4 T cells in mice 3 months after reconstitution were
assessed for NK1.1 and TCR-V8 expression.
hypothesized that mature CD4 T cells normally engage activation, perhaps by depleting intracellular intermedi-
ates required for TCR signaling (e.g., kinases) or by re-in repeated subthreshold interactions with self-MHC-II/
peptide complexes in the periphery. While these sub- cruiting negative regulators of TCR signaling (e.g., phos-
phatases). In this view, T cells continuously adapt orthreshold interactions do not themselves result in T cell
activation, each interaction increases the signaling tune their signaling thresholds to the environment that
they occupy. A prediction of the tuning model is thatthreshold that must be reached for subsequent T cell
Influence of Self-MHC-II on CD4 T Cell Reactivity
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Figure 6. Assessment of CD4CD25 T Cells
in Reconstituted Mice
(Left panel) Flow cytometric profiles of CD25
expression on gated CD4 T cells from lymph
nodes of mice 2 months after reconstitution
are shown. Histograms of CD4CD25 T cells
are from donor B6 (dashed line), reconstitu-
ted ZAPoMHC-II (solid line), and reconstitu-
ted ZAPoMHC-IIo (dotted line) mice.
(Right panel) Absolute numbers of
CD4CD25 T cells in the spleens of reconsti-
tuted ZAPoMHC-IIo (open bar) and ZAPoMHC-
II (solid bar) mice 2 months postreconstitu-
tion. Data are means 	 SEM.
surviving CD4 T cells should become more reactive as of ZAPoMHC-IIo hosts (MST of 15 and 11.5 days, respec-
tively). However, CD4CD25 regulatory T cells did notMHC-II expression declines.
The alternative perspective that we considered was seem to be the only mechanism by which MHC-II influ-
enced CD4 T cell reactivity, as MHC-II still affectedthat MHC-II expression might be required to maintain
CD4CD25 regulatory T cells that mediate self-toler- other measures of CD4 T cell reactivity even in the
absence of CD4CD25 regulatory T cells. For example,ance by inhibiting the reactivity of other CD4 T cells
(Sakaguchi, 2000; Shevach, 2001). Indeed, CD4CD25 CD4 T cells from ZAPoMHC-IIo and ZAPoMHC-II mice
that had been reconstituted with such CD4CD25 do-regulatory T cells have been shown to be important
mediators of self-tolerance, as their absence results in nor T cell populations differed in their in vitro reactivity to
anti-TCR stimulation, and ZAPoMHC-II mice that wereautoimmunity in a variety of experimental systems (Sa-
kaguchi, 2000). The mechanism by which CD4CD25 reconstituted with CD4CD25 donor T cells did not
develop the lymphoproliferative disorder that occurredregulatory T cells mediate self-tolerance and dampen
the reactivity of other CD4 T cells remains uncertain, in reconstituted ZAPoMHC-IIo mice. Thus, we think that
tuning and suppression may both be mechanisms bybut CD4CD25 regulatory T cells themselves are
thought to be regulated as a consequence of relatively which peripheral MHC-II influences CD4 T cell reactiv-
ity, although the two mechanisms may not be of equalhigh-affinity interactions with self-MHC-II peptide com-
plexes in the thymus and periphery that are just below importance.
It is interesting to speculate that tuning and suppres-the threshold for clonal deletion (Jordan et al., 2001).
We reasoned that peripheral MHC-II expression might sion might regulate the reactivity of different subpopula-
tions of CD4 T cells. One suggestion from the presenttherefore be critical for the suppressive function of
CD4CD25 regulatory T cells and for the maintenance study is that CD4 T cells are positively selected in the
thymus with sufficient affinity to become autoreactiveof self-tolerance.
In fact, we found that CD4CD25 regulatory T cells in the periphery if their reactivity potential is not actively
dampened. For CD4 T cells whose intrathymic select-disappeared after transfer into ZAPoMHC-IIo recipients
but were maintained in ZAPoMHC-II recipients. This ing ligands are expressed in the periphery, their reactiv-
ity can be dampened (tuned) by encounter with thosefinding supports the recent observation that CD4
CD25 regulatory T cells require MHC-II to undergo ho- self-MHC-II/peptide complexes. However, CD4 T cells
whose ligands are not encountered in the periphery can-meostatic proliferation (Gavin et al., 2002), but because
CD25 is an activation marker, it was conceivable that not be tuned and so are at risk of becoming hyperreac-
tive and functionally dysregulated. The reactivity ofCD4 regulatory T cells were present but did not express
the CD25 marker in reconstituted ZAPoMHC-IIo mice these CD4 T cells can then only be dampened by exog-
enous regulation. Thus, tuning might directly dampen(Gavin et al., 2002). However, experiments that will be
reported elsewhere demonstrate that CD4CD25 regu- the reactivity of CD4 T cells whose ligands are encoun-
tered in the periphery, but CD4CD25 regulatory T cellslatory T cells have limited survival in ZAPoMHC-IIo host
mice and that reconstituted ZAPoMHC-IIo host mice are would be required to dampen the reactivity of all other
CD4 T cells.in fact deficient in regulatory T cells (X.T. et al., unpub-
lished data).
In any event, the results of the present study demon- Conclusions
In conclusion, the present study demonstrates an impor-strated quite clearly that peripheral MHC-II expression
was required for maintaining CD4CD25 regulatory T tant role for peripheral MHC-II expression in regulating
the reactivity of memory CD4 T cells against both self-cells, and that at least part of the CD4 T cell hyperreac-
tivity that we observed could be directly attributed to and foreign antigens. Peripheral MHC-II exerts its effect
on CD4 T cell reactivity by maintaining CD4CD25the loss of donor CD4CD25 regulatory T cells in recon-
stituted ZAPoMHC-IIo mice. Specifically, CD4 T cell re- regulatory T cells that dampen the responsiveness of
other CD4 T cells. In addition, peripheral MHC-II canjection of bm12 skin grafts was significantly accelerated
in MHC-II host mice by depletion of CD4CD25 regu- influence the reactivity of CD4 T cells independently
of CD4CD25 regulatory T cells. Overall, the presentlatory T cells from the donor CD4 T cell inoculum to
the point that the rapidity of bm12 skin graft rejection study documents a role for peripheral MHC expression
in influencing T cell reactivity and self-tolerance.in reconstituted ZAPo MHC-II hosts approached that
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Figure 7. Reconstitution of Host Mice with CD4CD25 T Cells
(A) Donor T cell populations depleted of CD4CD25 regulatory T cells. Two-color flow cytometric profiles of CD4 versus CD25 expression
are shown on CD4 T cells (left) and CD4CD25 T cells (right).
(B) Comparison of bm12 skin allograft rejection by ZAPoMHC-II mice reconstituted with undepleted CD4 (filled circles) or CD4CD25 (open
circles) T cells.
(C) Comparison of in vitro reactivity of CD4CD25 T cells after residence in either ZAPoMHC-IIo or ZAPoMHC-II host mice. Splenocytes from
reconstituted ZAPoMHC-IIo (filled circles), reconstituted ZAPoMHC-II (open circles), or normal B6 (filled triangles) mice were stimulated
overnight with serial dilutions of anti-TCR mAb, stained, and assessed by multicolor flow cytometry. The percent of responding CD4
splenocytes that became CD69hi upon TCR stimulation is shown versus the concentration of stimulating anti-TCR mAb. Data are means 	
SEM. The in vitro reactivity to anti-TCR mAb of CD4 T cells obtained from CD4CD25 reconstituted ZAPoMHC-IIo mice was significantly
greater than that from CD4CD25 reconstituted ZAPoMHC-II mice (p  103).
(D) Histologic examination of skin from ZAPoMHC-II mice reconstituted with either undepleted CD4 T cells (left panel) or CD4CD25 T
cells (right panel) 3 months after reconstitution. No infiltration was seen in any MHC-II reconstituted mice. ZAPoMHC-II mice in this experiment
were also grafted with B6 (MHC-II) skin grafts, which were never rejected (data not shown).
Experimental Procedures and Development Center (Frederick, MD), and I-Abm12 (bm12) mice
were obtained from The Jackson Laboratory (Bar Harbor, ME).
Mice
In the present study, mice engineered to be deficient in ZAP-70 Antibodies Used for CD4 T Cell Purification and Flow Cytometry
CD4 T cells were purified from B6 lymph node cell populations(Negishi et al., 1995) (ZAPo) were bred to I-Ab deficient (Grusby et
al., 1991) (MHC-IIo) mice to generate ZAPoMHC-IIo and ZAPoMHC- by antibody-mediated negative selection for CD8, MHC-II, and Ig.
Single-cell suspensions of B6 lymph node cells were preincubatedIImice. B6 mice were obtained from the Frederick Cancer Research
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with mAb to CD8 (clone 2.43) and I-A (clone AF6-120.1, Phar- proliferation of naive peripheral CD4 T cells in the absence of self
peptide:MHC complexes. J. Immunol. 165, 2458–2464.mingen, CA), mixed with magnetic beads to which had been ad-
sorbed anti-Ig (Polysciences, Inc., PA), and then subjected to mag- Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist,
netic depletion. The resulting cell population was stained with mAbs C., and Mathis, D. (1991). Mice lacking MHC class II molecules. Cell
against CD4 (GK1.5), CD8 (clone 53-5.8, Pharmingen), B220 (clone 66, 1051–1066.
RA3-6B2, Pharmingen), and Thy1.2 (clone 30-H12, Pharmingen). Cyster, J.G., and Goodnow, C.C. (1997). Tuning antigen receptor
Peripheral blood and spleen cells from reconstituted mice were signaling by CD22: integrating cues from antigens and the microen-
stained with mAb against CD4 (GK1.5, Pharmingen), CD8 (CT- vironment. Immunity 6, 509–517.
CD8, Caltag), I-A (clone AF6-120.1, Pharmingen), CD44 (IM7,
Dorfman, J.R., Stefanova, I., Yasutomo, K., and Germain, R.N. (2000).Pharmingen), CD25 (PC61, Pharmingen), and CD62L (MEL-14, Phar-
CD4 T cell survival is not directly linked to self-MHC-induced TCRmingen), TCR- (H57-597), NK1.1 (PK136, Pharmingen), TCR-V8
signaling. Nat. Immunol. 1, 329–335.(KJ16). For in vitro stimulation with anti-TCR antibody, cells were
Ernst, B., Lee, D.S., Chang, J.M., Sprent, J., and Surh, C.D. (1999).stained with mAb against CD4, CD8, and CD69 (clone H1.2F3,
The peptide ligands mediating positive selection in the thymus con-Pharmingen). All cell populations were assessed by flow cytometry
trol T cell survival and homeostatic proliferation in the periphery.and gated on live cells by light scatter and propidium iodide ex-
Immunity 11, 173–181.clusion.
Fink, P.J., and Bevan, M.J. (1978). H-2 antigens of the thymus deter-
mine lymphocyte specificity. J. Exp. Med. 148, 766–775.Fractionation of Donor CD4 T Cells
Single-cell suspensions of B6 lymph node cells were preincubated Gavin, M.A., Clarke, S.R., Negrou, E., Gallegos, A., and Rudensky,
with mAb to CD8 (clone 2.43) and I-A (clone AF6-120.1), mixed A. (2002). Homeostasis and anergy of CD4()CD25() suppressor
with magnetic beads to which had been adsorbed anti-Ig, and then T cells in vivo. Nat. Immunol. 3, 33–41.
subjected to magnetic depletion. To fractionate donor CD4 T cells Grossman, Z., and Paul, W.E. (1992). Adaptive cellular interactions
according to CD44 expression, the resulting cell population was in the immune system: the tunable activation threshold and the
stained with mAbs against CD4 (GK1.5) and CD44 (clone 1M7), significance of subthreshold responses. Proc. Natl. Acad. Sci. USA
and the cells were electronically sorted into purified populations of 89, 10365–10369.
CD4CD44low and CD4CD44hi T cells. To purify CD4CD25 donor
Grossman, Z., and Singer, A. (1996). Tuning of activation thresholdsT cells, B6 CD4 T cell populations purified as before were incubated
explains flexibility in the selection and development of T cells in thewith anti-CD25 PE (clone PC61, Pharmingen), followed by deple-
thymus. Proc. Natl. Acad. Sci. USA 93, 14747–14752.tion using magnetic beads coupled to anti-PE antibodies (Miltenyi
Grusby, M.J., Johnson, R.S., Papaioannou, V.E., and Glimcher, L.H.Biotech).
(1991). Depletion of CD4 T cells in major histocompatibility com-
plex class II-deficient mice. Science 253, 1417–1420.Skin Grafts
Jordan, M.S., Boesteanu, A., Reed, A.J., Petrone, A.L., Holenbeck,Tailskin grafts were placed on the flanks of recipient mice. Bandages
A.E., Lerman, M.A., Naji, A., and Caton, A.J. (2001). Thymic selectionwere removed at day 7, and skin grafts were allowed to heal in for
of CD4CD25 regulatory T cells induced by an agonist self-pep-2–4 weeks before reconstitution with CD4 lymph node T cells.
tide. Nat. Immunol. 2, 301–306.Grafts were inspected every 1–2 days after CD4 T cell reconstitu-
tion and were considered to have been rejected when 20% of the Lucas, B., Stefanova, I., Yasutomo, K., Dautigny, N., and Germain,
graft remained. R.N. (1999). Divergent changes in the sensitivity of maturing T cells
to structurally related ligands underlies formation of a useful T cell
repertoire. Immunity 10, 367–376.In Vitro Anti-TCR Stimulation
Spleen cells were plated in 24-well plates at 2  106/ml together Lucas, B., and Germain, R.N. (2000). Opening a window on thymic
with serial dilutions of anti-TCRmAb (clone H57-597) and cultured positive selection: developmental changes in the influence of cosig-
for 16 hr, after which they were washed, stained, and assessed by naling by integrins and CD28 on selection events induced by TCR
flow cytometry for expression of CD4, CD8, and CD69. To assess engagement. J. Immunol. 165, 1889–1895.
the reactivity of CD4 T cells to anti-TCR stimulation, we calculated
McKenzie, I.F., Morgan, G.M., Sandrin, M.S., Michaelides, M.M.,
the frequency of CD4 T cells that became CD69hi in response to
Melvold, R.W., and Kohn, H.I. (1979). B6.C-H-2bm12. A new H-2
in vitro anti-TCR stimulation (Lucas and Germain, 2000).
mutation in the I region in the mouse. J. Exp. Med. 150, 1323–1338.
McKenzie, I.F., Henning, M.M., and Michaelides, M. (1984). Skin
Histology
graft rejection and delayed-type hypersensitivity responses to H-Y
Tissues of experimental mice were fixed in formalin, and then 10
in an I-Ab mutant. Immunogenetics 20, 475–480.
micron sections were stained with hematoxylin and eosin before
Mombaerts, P., Mizoguchi, E., Grusby, M.J., Glimcher, L.H., Bhan,examination by light microscopy. For immunohistochemistry, fixed
A.K., and Tonegawa, S. (1993). Spontaneous development of inflam-tissue sections were stained with fluoresceinated antibodies spe-
matory bowel disease in T cell receptor mutant mice. Cell 75,cific either for CD4 or CD8.
274–282.
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